Reports Dendreon (DNDN) Has Hired A Financial Advisor

According to FT.com's Mergermarket, Dendreon (Nasdaq: DNDN) has recently retained a financial adviser but the appointment is more likely to be a partnership deal as opposed to any near-term M&A.

According to Pharmawire, Dendreon has retained JP Morgan as financial advisor.

Takeover talk has been swirling around Dendreon since April when the company announced that its Phase III trial of Provenge met its primary endpoint.

Link to Mergermarket Article.

Real-Time Market Moving News Two-Weeks FREE http://www.streetinsider.com/premium_content.php